myocardial infarction complicated
by cardiogenic shock 68, 69
patients with unstable angina 4455 – – 77
risk of death 70
survival following 7733 – – 55
switch from sulphonylureas to
insulin after 8822 – – 33
total arterial revascularisation 7766 – – 88
Coronary Artery Study (CASS) 74
coronary heart disease (CHD)
antioxidant vitamins and 2244
lipid-lowering therapy 18
preventative 17
post-transplant 131
risk
blood pressure lowering and 7–8
hypertension and 1
Coxsackie titre, dilated
cardiomyopathy investigation
108
cyclophosphamide, transplant patients
129
cyclosporin-A, transplant patients
129, 130
dalteparin 44
death, sudden seesudden death
defibrillator, implantable see
implantable cardioverter
defibrillator
diabetic retinopathy, thrombolytic
therapy and 57–8
digoxin
heart failure patients 111166 – – 1177
paroxysmal atrial fibrillation 113333 – – 44
use in pregnancy 195
dihydropyridines
long-acting, chronic heart failure
114–15
short-acting, hypertension treatment,
cardiovascular risks 12
diltiazem
angina 35
unstable 43
role in atrial fibrillation
cardioversion 139
disopyramide, paroxysmal atrial
fibrillation 133
driving after myocardial infarction
6666 – – 77
DUKE study/score 29
dyslipidaemia drug therapy, choice
and monitoring 2200 – – 11
echocardiography
assessment of myocardial viability
3333 – – 44
dilated cardiomyopathy 108
dobutamine stress 33, 34, 210, 212
hypertrophic cardiomyopathy 101
relatives of patients 106, 107
myocardial contrast 33
transthoracic and transoesophageal
thrombus detection in left atrium
115511 – – 22
TIA and stroke patients 115533 – – 44
Eisenmenger syndrome 95, 96, 125
electric fences, pacemaker patients
and 168
electrocardiography (ECG)
dilated cardiomyopathy 108
exercise seeexercise tests
hypertrophic cardiomyopathy 101
relatives of patients 106, 107
implantable loop recorder 162
syncope monitoring 161–2
ELITE II trial 112
encephalopathy, hypertensive 15
endocarditis, infective
antibiotic prophylaxis 220088 – – 99
blood cultures 220077
indications for surgical management
220044 – – 55
risk
following valve replacement 94,
100
ventricular septal defect and 95
Ross procedure for aortic valve
replacement 92
enoxaparin 44
eptifibatide 44
European Coronary Surgery Study
(ECSS) 74
exercise tests
after myocardial infarction 5599 – – 6600
angina patients, disease prediction
2299 – – 3300
contraindications 2277 – – 88
diagnostic characteristics 2255 – – 66
dilated cardiomyopathy 108
effect of drugs on 27
guidelines 27
hypertrophic cardiomyopathy 102
predictive value 2255 – – 66
angina patients 2299 – – 3300
risks 2277 – – 88familial hypercholesterolaemia, drug
treatment 20, 21
felodipine, chronic heart failure 114–15
fibrates
drug interactions 23
dyslipidaemia 20–1
side effects 22–3218 Index